Skip to main content

ACG 2025 Annual Meeting Main banner

Icon Legend

This session is not in your Favorites.

This session is in your Favorites. Click again to remove it.

Presentation Icons

ACG Award Winner

ACG Award Winner

ACG Newsworthy Abstract

ACG Newsworthy Abstract

Registration Required

Registration Required

No CME

On-Demand Video

On-Demand Video

Livestream

Jessica R. Allegretti, MD, MPH, FACG photo

Jessica R. Allegretti, MD, MPH, FACG (she/her/hers)

Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women’s Hospital, Harvard Medical School

Poster(s):

P1147 - Efficacy of Guselkumab in Moderately to Severely Active Ulcerative Colitis by Extent of Disease and Inflammatory Burden: Subgroup Analysis of the Phase 3 QUASAR Maintenance Study

Sunday, October 26, 2025
3:30 PM - 7:00 PM MT
P1148 - Baseline Characteristics Associated With Probability of Remission and Greater Absolute Benefit of Treatment With Afimkibart (RO7790121/RG6631)

Sunday, October 26, 2025
3:30 PM - 7:00 PM MT
P1149 - Mirikizumab Sustains Improvement in Fatigue, Abdominal Pain, and Stool Frequency Following 104 Weeks of Continuous Treatment for Crohn’s Disease: Results From the VIVID-2 Open-Label Extension Study

Sunday, October 26, 2025
3:30 PM - 7:00 PM MT
P1150 - Effect of Subcutaneous Guselkumab on Bowel Urgency and Abdominal Pain as Measured by the UC-PRO/SS in Participants With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 ASTRO Study

Sunday, October 26, 2025
3:30 PM - 7:00 PM MT

Email Jessica